chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pt exp a warm, swollen, red shoulder & t100.9 p/vax; sxs were 10 times worse than the usual pain & swelling;
Patient experienced localized edema and redness around injection site. This presented the following day. Started small and then grew. At time of report the edema is at 7 cm by 8 cm. Patient did not present nor report and rapid heart beating and or shortness of breath.
36 hours after receiving the vaccine I was awakened at 4:00 AM 12/20/20 by muscle fasciculations- mostly in my legs. It was very bothersome and caused difficulty sleeping for a few days. The second week after the vaccine it seemed to get better. I?m due for my second dose tomorrow and the fasciculations are back as of a few days ago, around 1/4/21. I?m wondering if I should get the second dose.
Patient presents (6-26-03) with systemic vesicular rash temporal to anthrax vaccination site (6/24/03).  Vesicles are pustular and urticaric and are today invading the mucus membranes of the mouth.  Patient denies any N/V, or fever.  DX:  Erythema Multiforme with progression to Stevens-Johnson Syndrome.  Smallpox vaccination done on 6-8-03, site shows normal reaction with scabbing.
c/o of arm feeling funny, deneis any numbness, tingling or itching, monitored additional 15 minutes, denies any other complaints, symptoms improved and patient left after addidtional 15 minutes
At 8:30am the Vaccine was administered, about 5-8 minutes pt started feeling funny, burning sensation moved across her chest and had a funny taste, was anxious and lightheaded, looked flushed at different times. Had a small rash on under the left arm, felt the burning sensation about the chest a lot. After the being observed by the nurse and then rash developed, the nurse said: We better let ER observe the patient for a while.
I started feeling sick in Jun2021. trouble breathing and struggling to breathing and have not used rescue inhaler for 10 years Urgent care
C/O swelling behind ears bilaterally. Progressed over 3 days-to lower neck, lower jaw,under ears with hard clusters under ears.
This spontaneous report as received from a Medical Assistant refers to a patient of unknown age and gender. On 15-JUL-2015, the patient was vaccinated with an improperly stored dose of MMR II lot # K016154 with exp. 24-SEP-2016, (route and dose were not reported). No adverse effect reported. This is one of several reports received from the same reporter. Additional information has been requested.
I want to clarify above.  I had 3 total. vaccines: 1) J&J in April of 2021. 2) Moderna in Oct of 2021. 3) Moderna in March of 2022.   My ?adverse event? was:  I had symptoms of what I thought were spring allergies - post nasal drip and coughing.  The coughing kept getting worse to the point where I tested myself for Covid 19 and found that I was positive.  I also experienced some fatigue.  I?d say the symptoms lasted maybe 5 days. I talked to a nurse at my clinic over the phone.  I never needed to be seen by a doctor.  I recovered easily at home.
Parent called the day following vaccine administration, area was slightly tender, silver dollar sized area of redness and swelling in left arm.  Advised to apply cool compresses and give Motrin.
Hot body/ hot arm; Red arm; Really Swollen arm; really bad headache; chills; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Hot body/ hot arm), ERYTHEMA (Red arm), PERIPHERAL SWELLING (Really Swollen arm), HEADACHE (really bad headache) and CHILLS (chills) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included SALBUTAMOL (ASTHMA-SPRAY) and EPINEPHRINE (EPIPEN) for an unknown indication.   On 03-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-May-2021, the patient experienced FEELING HOT (Hot body/ hot arm), ERYTHEMA (Red arm), PERIPHERAL SWELLING (Really Swollen arm), HEADACHE (really bad headache) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, FEELING HOT (Hot body/ hot arm), ERYTHEMA (Red arm), PERIPHERAL SWELLING (Really Swollen arm), HEADACHE (really bad headache) and CHILLS (chills) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Purctic, indurated, erythamatous.  Fine papular rash, that started over L arm (DTAP site) spread across back and down to L leg
day following vax pt devel fever, rash & itching. redness & swelling lt leg.
Onset of nausea, vomiting, diarrhea at 6:00am- one day after vaccines. Cramping. On exam, no significant tenderness. Normal bowel sounds. 1cm erythema right deltoid. Induration & tenderness, without erythema on left deltoid.
Bumpiness(at injection site); Hot to touch((at injection site); Itchy all around injection site, 2-3inches in width; rash (at injection site); redness(around injection site); soreness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE NODULE (Bumpiness(at injection site)), VACCINATION SITE WARMTH (Hot to touch((at injection site)), VACCINATION SITE PRURITUS (Itchy all around injection site, 2-3inches in width), VACCINATION SITE RASH (rash (at injection site)) and VACCINATION SITE PAIN (soreness at injection site) in a 96-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Jan-2021, the patient experienced VACCINATION SITE PAIN (soreness at injection site). On 31-Jan-2021, the patient experienced VACCINATION SITE NODULE (Bumpiness(at injection site)), VACCINATION SITE WARMTH (Hot to touch((at injection site)), VACCINATION SITE PRURITUS (Itchy all around injection site, 2-3inches in width), VACCINATION SITE RASH (rash (at injection site)) and VACCINATION SITE ERYTHEMA (redness(around injection site)). At the time of the report, VACCINATION SITE NODULE (Bumpiness(at injection site)), VACCINATION SITE WARMTH (Hot to touch((at injection site)), VACCINATION SITE PRURITUS (Itchy all around injection site, 2-3inches in width), VACCINATION SITE RASH (rash (at injection site)), VACCINATION SITE PAIN (soreness at injection site) and VACCINATION SITE ERYTHEMA (redness(around injection site)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Mild reaction no SOB (notified Med Cont). Mild redness noted. 25 mg Benadryl (SL) given with immunization relief-no further care needed.
Fever 100.1, excessive tiredness, headache, achy all over, generally hurts all over to move. Large red knot about 2" in diameter at the shingles vaccine injection site and it hurts to touch or use that arm. You can feel the fever and warmth at the injection site. Taking IBU (2) 200mg each and drinking lots of fluids and resting. If I'm not better by Thursday or Friday, I'll contact my PCP.
I had stomach upset and felt horrible; had a soft stool, but not diarrhea; vomited several times; dry heaves.; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non pregnant female patient received first dose of BNT162B2 (COVID-19 MRNA VACCINE BIONTECH; Lot number: UNKNOWN) via unspecified route of administration in the left arm on 17Mar2021 at 10:00 (at the age of 62-years-old), as a single dose for COVID-19 immunisation. Medical history included hypertension. Concomitant medication included diltiazem (MANUFACTURER UNKNOWN) capsule 240 mg  and estradiol (MANUFACTURER UNKNOWN) tablet 2MG received within 2 weeks of vaccination.  Allergies to medications, food, or other products reported to Sulfa. Prior to the vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient had not been tested for COVID-19. The patient experienced stomach upset and felt horrible, had a soft stool, but not diarrhea and vomited several times and had the dry heaves on 18Mar2021 at 10:00. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the stomach upset, a soft stool, vomiting and dry heaves was resolving.   Information about lot/batch number cannot be obtained. No further information is expected.
Fever-started approximately 12 hours after 2nd shot.  Coughing,  wheezing, moderate headache.
Swollen left arm from shoulder to mid forearm with extensive bruising, discoloration, pain, and lack of movement.
Mild rash; This case was reported by a consumer via call center representative and described the occurrence of rash in a 46-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced rash. On an unknown date, the outcome of the rash was recovered/resolved.   It was unknown if the reporter considered the rash to be related to Shingrix.  Additional details were provided as follows: The reporter was the patient. The age at vaccination was not reported. The patient received first dose of Shingrix and experienced a mild rash. The reporter consented to follow-up and provided consent to contact health care professional. The patient experienced a more severe rash with her second dose of Shingrix, for tolerance of the 2nd dose, refer US2021AMR201228 reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR201228:same patient different dose
On 12/31/21, after Pfizer booster, I experienced severe joint pain throughout my body.  In addition, I experienced flu-like symptoms.  Both of these symptoms occur every 2-3 weeks lasting 1-2 day.s
Approx 5-15min after shot, pt c/o while in care with wife "sensation in arm- felt medicine gown arm, tongue felt "funny" throat scratchy", Patient not with her when wife called and gave the report.
Patient was given 2nd flu dose 16 days after the first dose. Patient did not experience any adverse reactions.
DEPRESSED; VERY BLURRY VISION; VERY FATIGUED; SIDE AND MIDDLE OF THROAT SWOLLEN; This spontaneous report received from a patient concerned a 55 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included hashimoto's disease, and reading glasses user. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported and batch number: 1808978 expiry: UNKNOWN) dose was not reported, administered on 02-APR-2021 for prophylactic vaccination. Concomitant medications included varicella zoster vaccine rge (cho) for prophylactic vaccination. On 02-APR-2021, the subject experienced side and middle of throat swollen. On 02-APR-2021, the subject experienced very fatigued. On 03-APR-2021, the subject experienced very blurry vision. On 04-APR-2021, the subject experienced depressed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from side and middle of throat swollen on 03-APR-2021, was recovering from very blurry vision, and had not recovered from very fatigued, and depressed. This report was non-serious.
Patient developed large, hard lump at injection site immediately following administration of ZOSTAVAX. I recommended he have it looked at by doctor. Resolved in 3 days.
RAPID GASPING BREATHS; SHAKES; CHILLS; WEAKNESS; NAUSEA; SPEECH LOSS/ COULD NOT TALK; FEVER; JOINT ACHES IN KNEES AND SHOULDERS; This spontaneous report received from a patient concerned a 53 year old male. The patient's height, and weight were not reported. The patient's past medical history included covid, and concurrent conditions included no alcohol use, and non smoker, and other pre-existing medical conditions included patient had no known drug allergies. patient had no drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Janssen1808978, expiry: UNKNWON) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced speech loss/ could not talk. On APR-2021, the subject experienced joint aches in knees and shoulders. On APR-2021, the subject experienced fever. On 09-APR-2021, the subject experienced rapid gasping breaths. On 09-APR-2021, the subject experienced shakes. On 09-APR-2021, the subject experienced chills. On 09-APR-2021, the subject experienced weakness. On 09-APR-2021, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from speech loss/ could not talk, rapid gasping breaths, shakes, and chills on APR-2021, was recovering from nausea, had not recovered from weakness, and fever, and the outcome of joint aches in knees and shoulders was not reported. This report was non-serious.; Sender's Comments: V0:Medical assessment comment not required as per standard procedure as case assessed as non serious.
there were no sx, just hearing loss;pt has a permanent hearing loss of 85%;dx sensory neuro bilateral;speech began to deteriorate shortly p/vax;  Per follow-up, the pt suffered from permanent hearing loss.
Redness, hard tangerine size, slightly raised, hot to the touch. Pt used Benadryl topically.  Pt told to use Benadryl orally and if not better or worse then see MD.
flu; Initial information was received on 12-Oct-2020 regarding an unsolicited valid non-serious case from a consumer/non-health care professional (patient) via social media. This case involves female patient (73 plus years) who had flu (influenza), while she received INFLUENZA VACCINE.  Medical history, medical treatment(s), vaccination(s), concomitant medications and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious flu (influenza) (unknown latency) following the administration of INFLUENZA VACCINE.  No laboratory data was provided   It was not reported if the patient received a corrective treatment.  At the time of report, the outcome of event was unknown.  There will be no information available on the batch number for this case
Extra Dose administered; pain; swelling; This case was reported by a pharmacist via call center representative and described the occurrence of pain in a 65-year-old female patient who received Herpes zoster (Shingrix) (batch number KJ9N5, expiry date 17th October 2021) for prophylaxis.   Previously administered products included Shingrix (received 2 doses at an unknown date).   On an unknown date, the patient received the 3rd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced extra dose administered. On an unknown date, the outcome of the extra dose administered was unknown.  Additional information received were as follows: The pharmacist on the line who administered the vaccine thought that it was the patient's second vaccine, but the patient called back letting her know that it was their third vaccine, which led to extra dose administered. The reporter consented to follow up. This case has been linked with US2019141361, reported by the same reporter.   Follow up information received by a pharmacist on 19th September 2019: The patient's demographics were updated. On 1st August 2019, the patient received the 3rd dose of 0.5 ml of Shingrix intramuscularly. The patient went into the pharmacy with her husband. They asked for the 2nd Shingles vaccine. The pharmacist gave it to them. Thus, patient's husband called later and stated this was actually their 3rd Shingrix shot. The patient's husband reported that less than a week after vaccination, the patient had pain and swelling similar to 2nd dose of Shingrix shot. The VAERS details were updated. It was unknown if the reporter considered the pain and swelling to be related to Shingrix.  For tolerance to 2nd dose, refer linked case US2019AMR179723.
Went into SVT two days after my second dose and have been feeling off balanced and fatigued ever since.
mild facial swelling; hyperhydrosis; intense fatigue; fever; chills/shivering; arm pain, general body aches; feeling uncomfortable; dizziness; intense vertigo; This spontaneous case was reported by a patient and describes the occurrence of FEELING ABNORMAL (feeling uncomfortable), DIZZINESS (dizziness), VERTIGO (intense vertigo), SWELLING FACE (mild facial swelling) and HYPERHIDROSIS (hyperhydrosis) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Colitis microscopic (It leads to hip lock due to diarrhea.), Hypothyroidism, Vertigo and Seasonal allergy. Concomitant products included LEVOFLOXACIN (LEVOXIN) for Hypothyroidism, ALPRAZOLAM and LORATADINE (CLARITINE ALLERGY) for an unknown indication.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Apr-2021, the patient experienced FEELING ABNORMAL (feeling uncomfortable), DIZZINESS (dizziness), VERTIGO (intense vertigo), FATIGUE (intense fatigue), PYREXIA (fever), CHILLS (chills/shivering) and MYALGIA (arm pain, general body aches). On 23-Apr-2021, the patient experienced SWELLING FACE (mild facial swelling) and HYPERHIDROSIS (hyperhydrosis). At the time of the report, FEELING ABNORMAL (feeling uncomfortable), DIZZINESS (dizziness), VERTIGO (intense vertigo), SWELLING FACE (mild facial swelling), HYPERHIDROSIS (hyperhydrosis), FATIGUE (intense fatigue), PYREXIA (fever), CHILLS (chills/shivering) and MYALGIA (arm pain, general body aches) outcome was unknown.            Patient was taking Multivitamins for supplemental purposes and Alprazolam for sleep. Treatment included Tylenol.   This case was linked to MOD-2021-089086 (Patient Link).
Her body felt like really heavy like a toner weight; extreme fatigue, spending most of the day resting; This spontaneous case was reported by a consumer and describes the occurrence of DISCOMFORT (Her body felt like really heavy like a toner weight) and FATIGUE (extreme fatigue, spending most of the day resting) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.     No Medical History information was reported.    On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DISCOMFORT (Her body felt like really heavy like a toner weight) and FATIGUE (extreme fatigue, spending most of the day resting). At the time of the report, DISCOMFORT (Her body felt like really heavy like a toner weight) and FATIGUE (extreme fatigue, spending most of the day resting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information and concomitant medications were reported.
it has worsened; her husband falling asleep in his chair and going to bed at 6.00 or 19.00 and sleeping until 9:00 or 10:00 the next morning; Fatigue; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A 70 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 02Mar2021 13:00 (Lot number: EM98089) at the age of 70 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "High cholesterol" (unspecified if ongoing); "High Blood Pressure" (unspecified if ongoing); "Digestive Issues" (unspecified if ongoing); "Stent" (unspecified if ongoing); "severe chest pain" (ongoing); "heart were blocked" (unspecified if ongoing); "helps with his heart" (unspecified if ongoing). Concomitant medication(s) included: NITRO [GLYCERYL TRINITRATE] taken for chest pain; CO-Q-10 PLUS; ASPIRIN CHILDREN taken for cardiac disorder. Vaccination history included: Bnt162b2 (Lot number: EN6198   , 1st dose), administration date: 09Feb2021, when the patient was 70 years old, for Covid-19 immunization. The following information was reported: FATIGUE (non-serious) with onset 03Mar2021, outcome "not recovered", described as "Fatigue"; CONDITION AGGRAVATED (non-serious), outcome "unknown", described as "it has worsened"; SOMNOLENCE (non-serious), outcome "unknown", described as "her husband falling asleep in his chair and going to bed at 6.00 or 19.00 and sleeping until 9:00 or 10:00 the next morning".  Additional information: Caller stated that she and her husband received their second dose of the Covid shot, clarified to be the Pfizer Covid-19 vaccine.  Caller reported later that both she and her husband have been experiencing fatigue. Caller reported that her husband started experiencing fatigue on 03Mar2021.  She stated that he was still experiencing the fatigue, and she believed that it has worsened.  Caller reported that she was unsure if it was connected to the vaccine, but that her husband falling asleep in his chair and going to bed at 6.00 or 19.00 and sleeping until 9:00 or 10:00 the next morning.  She stated that fatigue was a baseline for him but that she felt as though his has worsened since the second vaccine. Caller reported that her husband was on three different blood pressure medications in addition to medications for his stomach, heart, cholesterol, and nitro in case of severe chest pain.  Caller also reported that her husband saw a psychologist and was on a medication from that provider. The reporter stated that the patient has a long history of poor health.  No follow-up attempts are possible. No further information is expected.
Received SHINGRIX 50 mcg vaccine at local pharmacy per PCP advice and Rx. Within 6 hours developed egg-size very painful knot at injection site. Proceeded to develop serious neck and back pain with moderate headache, all of which precluded sleep that night. Symptoms continued on Day 2 along with general malaise. Since cannot take NSAIDs due to GI sensitivity, took 2.5mg of hydrocodone on afternoon of Day 2 and managed to get a couple of hours sleep. Symptoms began to subside late Day 2, but injection site remained hard and mildly painful while becoming inflamed. Day 3 was better with only mild pain and redness at injection site, however during Day 3 overnight, developed episodes of significant face and eye pain during sleep. Not sure this was related to injection, but it was something I never experienced before. At this time (morning Day 4), no significant pain, although injection site remains swollen and slightly red. Hopefully this is the end. I am a 66YO male in good health and am reporting this because this is by far the worst reaction I've ever had to any vaccination and feel like I've wasted 2 days of my life. Further, there was absolutely no advance warning that this could happen, although a little research on the internet suggests that these side effects are common. Consumers should know what to expect so they can make an informed decision. I'm not sure whether I would have gone through with the vaccination, knowing what I know now and I will be talking with my PCP about the second dose, due in 2 months.